The Cost-Effectiveness of Cyclooxygenase-2 Selective Inhibitors in the Management of Chronic Arthritis

Figure 3. The summary estimate is the relative risk ( ).
Figure 3. The summary estimate is the relative risk ( ). Meta-analysis using the fixed-effects model of randomized, controlled trials that report clinically significant ulcer complications (symptomatic ulcer, ulcer hemorrhage, or ulcer perforation) in patients receiving a coxib versus a nonselective nonsteroidal anti-inflammatory drug.RR

This Article

  1. Ann Intern Med May 20, 2003 vol. 138 no. 10 795-806
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. December 1, 2009, 151 (11)
  1. Alert me to current issues